Kiniksa Pharmaceuticals
KNSA
KNSA
61 hedge funds and large institutions have $224M invested in Kiniksa Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
24% less capital invested
Capital invested by funds: $295M → $224M (-$71.1M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
61
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.34M | |
| 2 | +$2.86M | |
| 3 | +$2.35M | |
| 4 |
BlackRock
New York
|
+$1.88M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.27M |
Top Sellers
| 1 | -$4.88M | |
| 2 | -$3.81M | |
| 3 | -$2.71M | |
| 4 |
NC
Nexthera Capital
New York
|
-$1.22M |
| 5 |
D.E. Shaw & Co
New York
|
-$936K |